Company Filing History:
Years Active: 2002-2017
Title: Scott F Sneddon: Innovator in TNF-α Signaling Modulation
Introduction
Scott F Sneddon is a prominent inventor based in Salem, MA (US). He has made significant contributions to the field of biomedical research, particularly in the modulation of TNF-α signaling. With a total of 6 patents to his name, Sneddon has established himself as a key figure in the development of therapeutic compounds.
Latest Patents
Among his latest patents, Sneddon has developed compounds that act as modulators of TNF-α signaling. These inventions provide methods for treating patients with TNF-α mediated conditions. The compounds can be represented by specific structural formulas, showcasing the innovative approaches he has taken in his research.
Career Highlights
Scott F Sneddon is associated with Genzyme Corporation, where he has been instrumental in advancing research and development in his area of expertise. His work has not only contributed to the scientific community but has also had a tangible impact on patient care.
Collaborations
Throughout his career, Sneddon has collaborated with notable colleagues, including John L Kane, Jr and Bradford Hirth. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Scott F Sneddon is a distinguished inventor whose work in TNF-α signaling modulation has the potential to transform treatment options for patients. His contributions to the field are invaluable, and his ongoing research continues to inspire advancements in biomedical science.